Industry News

Ecovia Bio To Expand Manufacturing Capacity

Series B funding will support significant expansion of manufacturing capacity at Ecovia Bio's Livonia facility.

Author Image

By: Lianna Albrizio

Associate Editor

Ecovia Bio, a biotechnology company specializing in sustainable, high-performance biopolymer ingredients, will expand its manufacturing capacity with the closure of a Series B funding round led by Detroit-based independent angel investor group Pointe Angels. The funding will support significant expansion of manufacturing capacity at Ecovia Bio’s Livonia facility to meet surging global demand for its AzuraBase and AzuraGel families of gamma polyglutamic acid (γ-PGA) and specialty biopoly...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters